Global Biosimulation Market 2021-2025

Global Biosimulation Market 2021-2025

  • July 2021 •
  • 120 pages •
  • Report ID: 6150292 •
  • Format: PDF
Global Biosimulation Market 2021-2025
The analyst has been monitoring the biosimulation market and it is poised to grow by $ 2.09 bn during 2021-2025, progressing at a CAGR of 13.17% during the forecast period. Our report on the biosimulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in research funding and grants and increase in M&A activities. In addition, increase in research funding and grants is anticipated to boost the growth of the market as well.
The biosimulation market analysis includes the end-user segment and geographic landscape.

The biosimulation market is segmented as below:
By End-user
• Contract research organizations
• Pharmaceutical and biotech companies
• Others

By Geographical Landscape
• North America
• Europe
• Asia

This study identifies the strategic initiatives by market vendors as one of the prime reasons driving the biosimulation market growth during the next few years.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on biosimulation market covers the following areas:
• Biosimulation market sizing
• Biosimulation market forecast
• Biosimulation market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimulation market vendors that include Cellworks Group Inc., Certara Inc., Chemical Computing Group ULC, Dassault Systemes SE, INOSIM Software GmbH, Insilico Biotechnology AG, LifeTec Group, Nuventra Pharma Sciences, Rosa & Co. LLC, and Simulations Plus Inc. Also, the biosimulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.